Ambry Genetics Launches GenomeNext and GenomeReveal for Rare Disease Diagnosis

Shots: Ambry Genetics has launched GenomeNext and GenomeReveal, a whole genome sequencing solution designed to improve diagnosis of rare diseases GenomeNext uses a pangenome reference to improve variant detection across diverse ancestral backgrounds, while GenomeReveal’s integrated RNA analysis provides additional evidence to help interpret certain DNA findings GenomeNext combines comprehensive genomic analysis, RNA evidence, and ongoing reanalysis to improve diagnostic opportunities for patients and provide updated insights Ref: Businesswire |   Image: Ambry Genetics |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Ambry Genetics Launches GenomeNext and GenomeReveal for Rare Disease Diagnosis appeared first on PharmaShots.